Syneron Bio
PrivateLast Round
Series B
Mar 31, 2026
Total Funding Raised
$250M
Company Overview
Syneron Bio is a biotechnology company that has developed an AI-powered platform, Synova, for the discovery and development of macrocyclic peptide therapeutics targeting oncology, autoimmune, metabolic, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Syneron Bio Comps
Public and private peers based on sector, stage, and business model.
Syneron Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 31, 2026 | ||||
| Series A | Dec 18, 2025 |
Syneron Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B |
| SV Health Investors | Series B |
| Biotech Development Fund | Series B |
| True Light Capital | Series B |
| GL Ventures | Series B, Series A |
| Decheng Capital | Series B |
| Pfizer Biotech Development Investment Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
$150M round raised.
- Dec 18, 2025
$100M round raised.
Syneron Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Syneron Bio's valuation, stock price, and market status.
